With Hopes High for New H.I.V. Prevention Pill, Merck Takes Steps to Ensure Access
The pharmaceutical company Merck said on Friday that it would license seven generic drugmakers to produce a low-cost version of a new monthly H.I.V. prevention pill that has generated significant…